New insight into the role of PTCH1 protein in serous ovarian carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New insight into the role of PTCH1 protein in serous ovarian carcinomas

Published:2022-10-05 Issue:6 Volume:61 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Karin‑Kujundzic Valentina¹,Covarrubias‑Pinto Adriana²,Skrtic Anita³,Vranic Semir⁴,Serman Ljiljana¹

Affiliation:

1. Department of Biology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia

2. Institute of Biochemistry II, School of Medicine, Goethe University, D‑60590 Frankfurt am Main, Germany

3. Centre of Excellence in Reproductive and Regenerative Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia

4. College of Medicine, QU Health, Qatar University, 2713 Doha, Qatar

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference47 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Progress and challenges in screening for early detection of ovarian cancer;Jacobs;Mol Cell Proteomics,2004

3. A systematic review of symptoms for the diagnosis of ovarian cancer;Ebell;Am J Prev Med,2016

4. Ovarian cancer;Matulonis;Nat Rev Dis Primers,2016

5. Ovarian carcinomas: At least five different diseases with distinct histological features and molecular genetics;Prat;Hum Pathol,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway;Oncogene;2024-08-03

2. Implicating clinical utility of altered expression of PTCH1 & SMO in oral squamous cell carcinoma;Journal of Molecular Histology;2024-07-01

3. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08

4. PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer;Frontiers in Oncology;2023-08-28

5. Overview on Screening and Prevalence of Ovarian Neoplasms in Saudi Arabia;Archives of Pharmacy Practice;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3